Activities per year
Activities
- 29 results
Search results
-
Prediction of venous thromboembolism risk associated with combined oral contraceptives: an exploratory model
Morimont, L. (Speaker) & Douxfils, J. (Speaker)
30 Nov 2023Activity: Talk or presentation types › Oral presentation
-
Navigating new regulations in biobanking for clinical studies and research projects
Douxfils, J. (Speaker)
4 Oct 2023Activity: Talk or presentation types › Oral presentation
-
Fantastic 4 - E4stetrol in Women's Health
Douxfils, J. (Invited speaker) & Foidart, J.-M. (Invited speaker)
4 May 2023 → 6 May 2023Activity: Talk or presentation types › Oral presentation
-
Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Douxfils, J. (Invited speaker)
24 Mar 2023Activity: Talk or presentation types › Oral presentation
-
Low Thrombin Generation in Menopausal Women Using Estetrol (E4)
Morimont, L. (Speaker) & Douxfils, J. (Speaker)
26 Oct 2022Activity: Talk or presentation types › Oral presentation
-
Correlation between activated protein C Resistance and the Relative Risk of Venous Thromboembolism in Women Using Hormonal Therapy
Morimont, L. (Speaker) & Douxfils, J. (Speaker)
11 May 2022 → 14 May 2022Activity: Talk or presentation types › Oral presentation
-
Estetrol (E4): a native estrogen whose effect on the liver does not need to be counterbalanced by progestins
Douxfils, J. (Speaker)
27 May 2022Activity: Talk or presentation types › Oral presentation
-
A new algorithm based on thrombin generation to assess hormone-relatedprothrombotic changes
Douxfils, J. (Invited speaker)
9 Jul 2019Activity: Talk or presentation types › Oral presentation
-
Clinical Debate: There is a need for DOAC testing in emergency situations and elective preoperative setting - YES
Douxfils, J. (Invited speaker)
14 Jun 2019Activity: Talk or presentation types › Oral presentation
-
Laboratory testing in patients treated with DOACs: a practical guide for clinicians
Douxfils, J. (Invited speaker)
20 Jun 2019Activity: Talk or presentation types › Oral presentation
-
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
21 Mar 2019Activity: Talk or presentation types › Oral presentation
-
Affections thromboemboliques veineuses – partie II
Douxfils, J. (Keynote speaker)
12 Mar 2019Activity: Talk or presentation types › Oral presentation
-
Interference of DOACs in coagulation tests
Douxfils, J. (Invited speaker)
9 Nov 2018Activity: Talk or presentation types › Oral presentation
-
Educational I - Should we measure DOACs?
Douxfils, J. (Invited speaker)
22 Nov 2018Activity: Talk or presentation types › Oral presentation
-
Nanoparticules dans les peintures : quels risques pour la santé?
Laloy, J. (Speaker)
23 Mar 2018Activity: Talk or presentation types › Oral presentation
-
DOACs: new test on development
Douxfils, J. (Speaker)
2 Mar 2018Activity: Talk or presentation types › Oral presentation
-
Spin-off et financement - Présentation de QUALIblood
Gheldof, D. (Speaker) & Douxfils, J. (Speaker)
6 Mar 2018Activity: Talk or presentation types › Oral presentation
-
In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions
Haguet, H. (Speaker), Douxfils, J. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker), Mullier, F. (Speaker) & Dogne, J.-M. (Speaker)
9 Feb 2018Activity: Talk or presentation types › Oral presentation
-
Nanoparticules dans les peintures: quels risques pour la santé?
Laloy, J. (Speaker)
2018Activity: Talk or presentation types › Oral presentation
-
Assessment of thrombin generation in plasma samples of patients under anticoagulant treatment with ST Genesia system using STG – DrugScreen
Douxfils, J. (Speaker)
29 Jun 2017Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
25 Feb 2017Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
28 Apr 2016Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
29 Jan 2016Activity: Talk or presentation types › Oral presentation
-
Risk of cardiovascular events associated with BCR-ABL TKI in leukemic population: a systematic review and meta-analysis
Douxfils, J. (Speaker), Haguet, H. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
Jun 2015Activity: Talk or presentation types › Oral presentation
-
Hemocompatibility of nanoparticles: impact on fibrinolysis.
Laloy, J. (Speaker)
2014Activity: Talk or presentation types › Oral presentation
-
Effect of dabigatran etexilate on the risk of myocardial infarction and other cardiac events: A systematic review and updated dose-response meta-analysis of randomized controlled trials
Douxfils, J. (Speaker)
1 Jul 2013Activity: Talk or presentation types › Oral presentation
-
Hemocompatibility of manufactured nanoparticles: Guidelines proposal.
Laloy, J. (Speaker)
2013Activity: Talk or presentation types › Oral presentation
-
Assessment of different methods studying the impact of carbon nanomaterials on platelet function.
Laloy, J. (Speaker)
2012Activity: Talk or presentation types › Oral presentation
-
Impact of nanomaterials on human health: Strategies of the Namur Nanosafety Center (NNC).
Laloy, J. (Speaker)
2012Activity: Talk or presentation types › Oral presentation